CNS pipeline · person
Susan Altschuller, PhD, MBA
Chief Financial Officer of Cerevel Therapeutics, appointed effective May 15, 2023 (succeeding interim CFO Mark Bodenrader). Previously Chief Financial Officer of ImmunoGen.
- 1 company
Courtesy Cerevel Therapeutics
Current roles
- Cerevel Therapeutics Holdings, Inc.Chief Financial Officer · Executive2023–present
Appears with
People sharing a company with Susan.
- Adam Koppel · Cerevel Therapeutics Holdings, Inc.
- Christopher Gordon · Cerevel Therapeutics Holdings, Inc.
- Deborah Baron · Cerevel Therapeutics Holdings, Inc.
- Deval Patrick · Cerevel Therapeutics Holdings, Inc.
- Doug Giordano · Cerevel Therapeutics Holdings, Inc.
- Gabrielle Sulzberger · Cerevel Therapeutics Holdings, Inc.
- John Renger · Cerevel Therapeutics Holdings, Inc.
- Kathleen Tregoning · Cerevel Therapeutics Holdings, Inc.
- Kenneth DiPietro · Cerevel Therapeutics Holdings, Inc.
- Marijn Dekkers · Cerevel Therapeutics Holdings, Inc.
- Mark Bodenrader · Cerevel Therapeutics Holdings, Inc.
- N. Anthony Coles · Cerevel Therapeutics Holdings, Inc.
- Norbert G. Riedel · Cerevel Therapeutics Holdings, Inc.
- Paul Burgess · Cerevel Therapeutics Holdings, Inc.
- Raymond Sanchez · Cerevel Therapeutics Holdings, Inc.
- Ron Renaud · Cerevel Therapeutics Holdings, Inc.
- Ruth McKernan · Cerevel Therapeutics Holdings, Inc.
- Scott Akamine · Cerevel Therapeutics Holdings, Inc.
- Suneet Varma · Cerevel Therapeutics Holdings, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.